Anton Trochanov Email

VP, Head Medical Safety and Pharmacovigilance . Replimune

Current Roles

Employees:
424
Revenue:
$17.8M
About
Replimune is working to advance the science of oncolytic immunotherapy to improve on existing therapies and help treat more patients with a variety of tumor types. Oncolytic immunotherapy uses viruses that have been modified to selectively replicate in and kill tumors. Replimunes' goal is to develop powerful therapies to overcome cancer.
Replimune Address
500 Unicorn Park Dr
Woburn, MA
United States
Replimune Email

Past Companies

Global PV & Drug Safety Consulting, IncPresident
ReplimuneVice President, Head of Medical Safety and Pharmacovigilance
La Jolla Pharmaceutical CompanyVice President, Head of Global Drug Safety

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.